{"id":20814,"date":"2023-10-26T17:14:04","date_gmt":"2023-10-26T15:14:04","guid":{"rendered":"https:\/\/ggba.swiss\/debiopharm-invests-chf-30-million-in-valais-amidst-workforce-surge\/"},"modified":"2023-10-26T17:16:16","modified_gmt":"2023-10-26T15:16:16","slug":"debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/","title":{"rendered":"Debiopharm augmente ses effectifs et investit CHF 30 millions en Valais"},"content":{"rendered":"\n

Le secteur pharmaceutique valaisan est en pleine effervescence. Debiopharm Research & Manufacturing (Debiopharm<\/a>) a d\u00e9voil\u00e9 le projet d’un nouveau b\u00e2timent d’innovation \u00e0 Martigny. Cet investissement majeur s’accompagne d’une croissance de 33% de ses effectifs dans la r\u00e9gion.<\/p>\n\n\n\n

La c\u00e9r\u00e9monie de pose de la premi\u00e8re pierre s’est d\u00e9roul\u00e9e en pr\u00e9sence de personnalit\u00e9s telles que Christophe Darbelley, Pr\u00e9sident du Conseil d’Etat du Valais, et de repr\u00e9sentants de la Haute Ecole d’Ing\u00e9nierie du Valais<\/a>. Le nouveau b\u00e2timent, qui repr\u00e9sente un investissement de plus de CHF 30 millions, fait partie int\u00e9grante des CHF 150 millions d’investissement projet\u00e9s par Debiopharm depuis l’an 2000. Ces investissements ont \u00e9t\u00e9 en grande partie consacr\u00e9s \u00e0 la r\u00e9novation des laboratoires et \u00e0 la modernisation de l’usine de production.<\/p>\n\n\n\n

Le principal produit de l’usine, la triptor\u00e9line, un traitement \u00e9prouv\u00e9 pour des maladies telles que le cancer de la prostate et du sein, ainsi que la pubert\u00e9 pr\u00e9coce, est prescrit dans plus de 90 pays. Thierry Mauvernay, Pr\u00e9sident et Directeur g\u00e9n\u00e9ral de Debiopharm, a d\u00e9clar\u00e9 : \u00ab Nous consacrons plus de 90 % de nos revenus \u00e0 l’innovation, et notre ambition va au-del\u00e0 du traitement du cancer, pour aller jusqu’\u00e0 la gu\u00e9rison du cancer. \u00bb<\/p>\n\n\n\n

Con\u00e7u pour r\u00e9pondre aux normes environnementales actuelles, le nouveau b\u00e2timent d’innovation de quatre \u00e9tages s’\u00e9tendra sur 2’400 m\u00e8tres carr\u00e9s. Il constituera un p\u00f4le de recherche pionni\u00e8re en oncologie et renforcera la r\u00e9putation de Debiopharm dans l’industrie pharmaceutique.<\/p>\n\n\n\n

Expansion rapide et avanc\u00e9es pionni\u00e8res<\/h4>\n\n\n\n

La croissance r\u00e9cente du site de Debiopharm \u00e0 Martigny a \u00e9t\u00e9 fulgurante. C\u00e9dric Sager, CEO de Debiopharm Research & Manufacturing, a comment\u00e9 la vague d’embauches : \u00ab En l’espace d’un an, nous avons engag\u00e9 plus de 50 nouveaux collaborateurs \u00bb. L’entreprise pr\u00e9voit que ses efforts d’expansion se poursuivront dans les ann\u00e9es \u00e0 venir, une grande partie des nouvelles recrues se concentrant sur la recherche et le d\u00e9veloppement.<\/p>\n\n\n\n

Les collaborations et les avanc\u00e9es de la recherche t\u00e9moignent de l’engagement de l’entreprise en faveur de l’innovation dans le domaine de l’oncologie. Sa collaboration avec la HES-SO Valais-Wallis<\/a> a conduit au d\u00e9veloppement de deux technologies prometteuses de lutte contre le cancer, Multilink\u2122 et AbYlink\u2122. Des essais cliniques utilisant ces techniques r\u00e9volutionnaires devraient d\u00e9buter d\u00e8s l’ann\u00e9e prochaine.<\/p>\n\n\n\n

Pour renforcer encore ses r\u00e9f\u00e9rences en mati\u00e8re de recherche, Debiopharm a r\u00e9cemment engag\u00e9 CHF 1,1 million dans un partenariat avec l’Institut des technologies des sciences de la vie de la Haute \u00e9cole d’ing\u00e9nieurs. Cette collaboration vise \u00e0 d\u00e9velopper des conjugu\u00e9s th\u00e9rapeutiques ciblant les cellules canc\u00e9reuses, t\u00e9moignant de l’engagement de Debiopharm en faveur de traitements innovants minimisant les effets secondaires.<\/p>\n","protected":false},"excerpt":{"rendered":"

Debiopharm Research & Manufacturing a annonc\u00e9 un investissement de plus de CHF 30 millions dans l’agrandissement de son laboratoire de Martigny, alors que ses effectifs sont pass\u00e9s de 150 \u00e0 200 collaborateurs en l’espace d’un an.<\/p>\n","protected":false},"author":6,"featured_media":20810,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1169,1154,1140,1171,1142],"class_list":["post-20814","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr-2","tag-investment-fr-2","tag-oncology-fr-2","tag-pharma-fr-2","tag-rd-fr-2"],"acf":[],"yoast_head":"\nDebiopharm augmente ses effectifs et investit CHF 30M en Valais<\/title>\n<meta name=\"description\" content=\"Debiopharm a annonc\u00e9 un investissement de plus de CHF 30 millions dans l'agrandissement de son laboratoire de Martigny.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Debiopharm augmente ses effectifs et investit CHF 30M en Valais\" \/>\n<meta property=\"og:description\" content=\"Debiopharm a annonc\u00e9 un investissement de plus de CHF 30 millions dans l'agrandissement de son laboratoire de Martigny.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-26T15:14:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-26T15:16:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Debiopharm augmente ses effectifs et investit CHF 30 millions en Valais\",\"datePublished\":\"2023-10-26T15:14:04+00:00\",\"dateModified\":\"2023-10-26T15:16:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/\"},\"wordCount\":495,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg\",\"keywords\":[\"Biotech\",\"Investment\",\"Oncology\",\"Pharma\",\"R&D\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/\",\"name\":\"Debiopharm augmente ses effectifs et investit CHF 30M en Valais\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg\",\"datePublished\":\"2023-10-26T15:14:04+00:00\",\"dateModified\":\"2023-10-26T15:16:16+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Debiopharm a annonc\u00e9 un investissement de plus de CHF 30 millions dans l'agrandissement de son laboratoire de Martigny.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"\u00c9tabli dans le canton du Valais depuis 1989, Debiopharm construit un v\u00e9ritable campus de recherche et d'innovation \u00e0 Martigny. | \u00a9 Sacha Bittel \/ Le Nouvelliste\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Debiopharm augmente ses effectifs et investit CHF 30 millions en Valais\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Debiopharm augmente ses effectifs et investit CHF 30M en Valais","description":"Debiopharm a annonc\u00e9 un investissement de plus de CHF 30 millions dans l'agrandissement de son laboratoire de Martigny.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/","og_locale":"fr_FR","og_type":"article","og_title":"Debiopharm augmente ses effectifs et investit CHF 30M en Valais","og_description":"Debiopharm a annonc\u00e9 un investissement de plus de CHF 30 millions dans l'agrandissement de son laboratoire de Martigny.","og_url":"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2023-10-26T15:14:04+00:00","article_modified_time":"2023-10-26T15:16:16+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Debiopharm augmente ses effectifs et investit CHF 30 millions en Valais","datePublished":"2023-10-26T15:14:04+00:00","dateModified":"2023-10-26T15:16:16+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/"},"wordCount":495,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg","keywords":["Biotech","Investment","Oncology","Pharma","R&D"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/","url":"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/","name":"Debiopharm augmente ses effectifs et investit CHF 30M en Valais","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg","datePublished":"2023-10-26T15:14:04+00:00","dateModified":"2023-10-26T15:16:16+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Debiopharm a annonc\u00e9 un investissement de plus de CHF 30 millions dans l'agrandissement de son laboratoire de Martigny.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2023\/10\/Debiopharm-Sasha-Bittel-1180x811-1.jpg","width":1180,"height":811,"caption":"\u00c9tabli dans le canton du Valais depuis 1989, Debiopharm construit un v\u00e9ritable campus de recherche et d'innovation \u00e0 Martigny. | \u00a9 Sacha Bittel \/ Le Nouvelliste"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/debiopharm-augmente-ses-effectifs-et-investit-chf-30-millions-en-valais\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Debiopharm augmente ses effectifs et investit CHF 30 millions en Valais"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/20814","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=20814"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/20814\/revisions"}],"predecessor-version":[{"id":20816,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/20814\/revisions\/20816"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/20810"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=20814"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=20814"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=20814"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}